316 related articles for article (PubMed ID: 32886697)
1. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
[TBL] [Abstract][Full Text] [Related]
2. Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.
Gu L; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092701
[No Abstract] [Full Text] [Related]
3. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
4. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
[TBL] [Abstract][Full Text] [Related]
5. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure.
Aimo A; Vergaro G; Ripoli A; Bayes-Genis A; Pascual Figal DA; de Boer RA; Lassus J; Mebazaa A; Gayat E; Breidthardt T; Sabti Z; Mueller C; Brunner-La Rocca HP; Tang WH; Grodin JL; Zhang Y; Bettencourt P; Maisel AS; Passino C; Januzzi JL; Emdin M
JACC Heart Fail; 2017 Apr; 5(4):287-296. PubMed ID: 28189578
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.
Jha D; Goenka L; Ramamoorthy T; Sharma M; Dhandapani VE; George M
Eur J Clin Invest; 2018 Sep; 48(9):e12994. PubMed ID: 29992539
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure.
Gül İ; Yücel O; Zararsız A; Demirpençe Ö; Yücel H; Zorlu A; Yılmaz MB
Anatol J Cardiol; 2017 Sep; 18(3):200-205. PubMed ID: 28761021
[TBL] [Abstract][Full Text] [Related]
9. Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI.
Liu X; Hu Y; Huang W; Zhang G; Cao S; Yan X; Li L; Zhang L; Zheng X
Int Heart J; 2019 Jan; 60(1):19-26. PubMed ID: 30464124
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis.
Aimo A; Vergaro G; Passino C; Ripoli A; Ky B; Miller WL; Bayes-Genis A; Anand I; Januzzi JL; Emdin M
JACC Heart Fail; 2017 Apr; 5(4):280-286. PubMed ID: 27816512
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
[TBL] [Abstract][Full Text] [Related]
12. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
13. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of coronary CT angiography in heart failure patients with preserved ejection fraction.
Yu MM; Zuo WX; Zhao X; Tang XL; Chen YY; Dong LL; Shu XH; Jin H; Zeng MS
Eur Radiol; 2023 May; 33(5):3052-3063. PubMed ID: 36629927
[TBL] [Abstract][Full Text] [Related]
15. The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis.
Zhang S; Ding Y; Feng F; Gao Y
Front Cardiovasc Med; 2022; 9():938540. PubMed ID: 35966557
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis.
Guo G; Huang A; Huang X; Xu T; Yao L
Dis Markers; 2021; 2021():8881393. PubMed ID: 33574967
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognostic importance of high levels of sST2 in patient with AMI: a meta-analysis.
Ji H; Yuan L; Jiang W; Chen J
Am J Transl Res; 2024; 16(1):1-11. PubMed ID: 38322566
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease.
Chou HH; Hsu LA; Juang JJ; Chiang FT; Teng MS; Wu S; Ko YL
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457109
[TBL] [Abstract][Full Text] [Related]
19. Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose-response meta-analysis of prospective studies.
Li Y; Pei H; Zhou C
Biomarkers; 2019 Sep; 24(6):556-565. PubMed ID: 30974974
[No Abstract] [Full Text] [Related]
20. ST2 elevation in heart failure, predictive of a high early mortality.
Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]